Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,241 | 900 | 0 | 0 | N/A |
| Other current assets | 0 | 35 | 0 | 0 | 0 |
| TOTAL | $7,894 | $1,390 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 18 | 8 | N/A | N/A | N/A |
| TOTAL | $18 | $8 | $N/A | $N/A | $N/A |
| Total Assets | $7,912 | $1,398 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 300 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 290 | 288 | 0 | 0 | 0 |
| Accrued Expenses | 22 | 46 | 0 | 0 | N/A |
| Other current liabilities | N/A | 763 | 0 | 0 | N/A |
| TOTAL | $311 | $1,398 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $311 | $1,398 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 17 | 14 | 0 | 0 | N/A |
| Retained earnings | -11,489 | -8,961 | 0 | 0 | N/A |
| TOTAL | $7,601 | $0 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $7,912 | $1,398 | $0 | $0 | $0 |